Genmab A/S
GNMSF
$274.75
$9.913.74%
OTC PK
| 06/30/2025 | 06/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 72.31% | 72.31% | -66.25% | -64.51% | 209.75% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 50.50% | -2.65% | -35.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18,600.00% | -18,600.00% | 100.57% | 100.54% | -200.16% |
| Change in Net Operating Assets | -240.00% | -240.00% | 6,023.95% | 837.13% | 101.59% |
| Cash from Operations | -78.40% | -78.40% | -32.26% | -25.95% | 41.43% |
| Capital Expenditure | 16.67% | 16.67% | 14.83% | 10.67% | -151.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 216.13% | 216.13% | -184.31% | -223.25% | -4.76% |
| Cash from Investing | 160.47% | 160.47% | 28.70% | -466.93% | -282.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -100.00% | -100.00% | -198.20% | -- | 96.05% |
| Issuance of Common Stock | 500.00% | 500.00% | -61.82% | -90.91% | -93.91% |
| Repurchase of Common Stock | -3,300.00% | -3,300.00% | 48.91% | -50.00% | 92.22% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3,023.08% | -3,023.08% | 39.65% | -3,132.42% | 47.04% |
| Foreign Exchange rate Adjustments | -162.50% | -162.50% | -54.56% | -92.21% | 298.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -235.15% | -235.15% | -33.51% | -52.44% | 21.30% |